We are live on ! Find out more
Citadel Advisors

Citadel Advisors Portfolio holdings

AUM $875B
1-Year Est. Return 40.91%
 

Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.

This Fund
S&P 500
This Quarter Est. Return
-13.42%
1 Year Est. Return
+40.91%
3 Year Est. Return
+115.85%
5 Year Est. Return
+132.1%
10 Year Est. Return
+518.81%
AUM
$390B
AUM Growth
-$94.7B
Cap. Flow
+$10.4B
Cap. Flow %
2.66%
Top 10 Hldgs %
28.21%
Holding
14,957
New
1,520
Increased
5,503
Reduced
5,522
Closed
2,191

Sector Composition

Rank Sector Weight
1 Healthcare 2.83%
2 Technology 2.79%
3 Financials 2.29%
4 Consumer Discretionary 1.93%
5 Industrials 1.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LRMR icon
12176
Larimar Therapeutics
LRMR
$453M
$27K ﹤0.01%
13,676
+779
+6% +$2.3K
LITS
12177
PUT
Lite Strategy Inc
LITS
$30.2M
$27K ﹤0.01%
2,195
+150
+7% +$1.63K
RCON icon
12178
CALL
Recon Technology
RCON
$2.32M
$27K ﹤0.01%
2,244
-934
-29% -$14.1K
LNAI
12179
CALL
Lunai Bioworks
LNAI
$10.1M
$27K ﹤0.01%
174
+46
+36% +$21K
SPRO icon
12180
PUT
Spero Therapeutics
SPRO
$71.6M
$27K ﹤0.01%
+36,600
New +$106K
VNRX icon
12181
PUT
VolitionRx Ltd
VNRX
$6.89M
$27K ﹤0.01%
+665
New +$33.5K
WRAP icon
12182
PUT
Wrap Technologies
WRAP
$105M
$27K ﹤0.01%
14,300
-1,300
-8% -$3.08K
BTCY
12183
DELISTED
Biotricity, Inc. Common Stock
BTCY
$27K ﹤0.01%
2,529
-7,206
-74% -$62.9K
AFIB
12184
CALL
DELISTED
Acutus Medical Inc
AFIB
$27K ﹤0.01%
24,300
-29,900
-55% -$25.7K
VIEW
12185
DELISTED
View, Inc. Class A Common Stock
VIEW
$27K ﹤0.01%
283
-8,915
-97% -$793K
IDEX
12186
PUT
DELISTED
Ideanomics, Inc. Common Stock
IDEX
$27K ﹤0.01%
321
-520
-62% -$46.8K
TRKA
12187
DELISTED
Troika Media Group, Inc. Common Stock
TRKA
$27K ﹤0.01%
1,420
+303
+27% +$5.72K
BLTSW
12188
DELISTED
Bright Lights Acquisition Corp. Warrant
BLTSW
$27K ﹤0.01%
335,541
+1,433
+0.4% +$573
BAOS icon
12189
Baosheng Media Group
BAOS
$767K
$26K ﹤0.01%
3,779
+2,007
+113% +$19.2K
BCDA icon
12190
BioCardia
BCDA
$14.7M
$26K ﹤0.01%
1,178
-1,735
-60% -$41.5K
BKSY icon
12191
BlackSky Technology
BKSY
$1.27B
$26K ﹤0.01%
1,420
-70,806
-98% -$1.08M
ENIC icon
12192
CALL
Enel Chile
ENIC
$6.27B
$26K ﹤0.01%
23,400
+4,200
+22% +$5.79K
HEPA
12193
CALL
DELISTED
Hepion Pharmaceuticals
HEPA
$26K ﹤0.01%
45
-22
-33% -$18.3K
MNOV icon
12194
CALL
MediciNova
MNOV
$64.5M
$26K ﹤0.01%
+10,400
New +$27.1K
WWR icon
12195
PUT
Westwater Resources
WWR
$72.7M
$26K ﹤0.01%
24,300
-21,200
-47% -$27.6K
LFWD icon
12196
CALL
ReWalk Robotics
LFWD
$21M
$26K ﹤0.01%
330
+44
+15% +$3.74K
CRKN
12197
DELISTED
Crown Electrokinetics Corp. Common Stock
CRKN
0
AXLA
12198
DELISTED
Axcella Health Inc. Common Stock
AXLA
$26K ﹤0.01%
+511
New +$25.1K
REUN
12199
DELISTED
Reunion Neuroscience Inc. Common Shares
REUN
$26K ﹤0.01%
6,206
+1,332
+27% +$6.66K
CUEN
12200
DELISTED
Cuentas Inc. Common Stock
CUEN
$26K ﹤0.01%
3,223
+2,434
+308% +$27.8K

Similar funds

Citadel Advisors's Q2 2022 Portfolio in Review

As of Q2 2022, Citadel Advisors held 14,957 positions worth $390B, down 20% from $484B the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Citadel Advisors's Q2 2022 filing shows 1,520 new, 5,503 increased, 5,522 reduced and 2,191 closed positions. Its largest new stake was ResMed: 1,280,595 shares worth $268M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $576M.

By sector, the portfolio is most concentrated in Healthcare at 2.8% of assets, up from 2.4% a quarter earlier, followed by Technology and Financials.

  • Citadel Advisors's largest Q2 2022 buy was ResMed: 1,280,595 shares worth $268M.
  • Citadel Advisors added most to Meta Platforms (Facebook) in Q2 2022, an estimated $772M increase.
  • Citadel Advisors's biggest Q2 2022 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $576M.
  • Citadel Advisors fully exited Vanguard Morningstar Small-Cap ETF in Q2 2022, selling an estimated $184M.
  • Citadel Advisors's ten largest holdings make up 28% of its $390B portfolio in Q2 2022.
  • Citadel Advisors opened 1,520 new positions and closed 2,191 in Q2 2022.
  • Citadel Advisors's portfolio value fell 20% quarter-over-quarter to $390B.

Based on Citadel Advisors's 13F filing for Q2 2022, filed 15 Aug 2022.